Open Access

[Retracted] Tumor suppressor role of miR-217 in human epithelial ovarian cancer by targeting IGF1R

  • Authors:
    • Jieyan Li
    • Dongmei Li
    • Weiyuan Zhang
  • View Affiliations

  • Published online on: September 26, 2022     https://doi.org/10.3892/or.2022.8415
  • Article Number: 200
  • Copyright : © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

November-2022
Volume 48 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li J, Li D and Zhang W: [Retracted] Tumor suppressor role of miR-217 in human epithelial ovarian cancer by targeting IGF1R. Oncol Rep 48: 200, 2022.
APA
Li, J., Li, D., & Zhang, W. (2022). [Retracted] Tumor suppressor role of miR-217 in human epithelial ovarian cancer by targeting IGF1R. Oncology Reports, 48, 200. https://doi.org/10.3892/or.2022.8415
MLA
Li, J., Li, D., Zhang, W."[Retracted] Tumor suppressor role of miR-217 in human epithelial ovarian cancer by targeting IGF1R". Oncology Reports 48.5 (2022): 200.
Chicago
Li, J., Li, D., Zhang, W."[Retracted] Tumor suppressor role of miR-217 in human epithelial ovarian cancer by targeting IGF1R". Oncology Reports 48, no. 5 (2022): 200. https://doi.org/10.3892/or.2022.8415